These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34997924)

  • 21. Development and validation of a risk prediction model for chronic kidney disease among individuals with type 2 diabetes.
    Lin CC; Niu MJ; Li CI; Liu CS; Lin CH; Yang SY; Li TC
    Sci Rep; 2022 Mar; 12(1):4794. PubMed ID: 35314714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation of a Novel Predictive Algorithm for Kidney Failure in Patients Suffering from Chronic Kidney Disease: The Prognostic Reasoning System for Chronic Kidney Disease (PROGRES-CKD).
    Bellocchio F; Lonati C; Ion Titapiccolo J; Nadal J; Meiselbach H; Schmid M; Baerthlein B; Tschulena U; Schneider M; Schultheiss UT; Barbieri C; Moore C; Steppan S; Eckardt KU; Stuard S; Neri L
    Int J Environ Res Public Health; 2021 Nov; 18(23):. PubMed ID: 34886378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between cardiac biomarkers and the development of ESRD in patients with type 2 diabetes mellitus, anemia, and CKD.
    Desai AS; Toto R; Jarolim P; Uno H; Eckardt KU; Kewalramani R; Levey AS; Lewis EF; McMurray JJ; Parving HH; Solomon SD; Pfeffer MA
    Am J Kidney Dis; 2011 Nov; 58(5):717-28. PubMed ID: 21820220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Derivation and validation of a prognostic model to predict mortality in patients with advanced chronic kidney disease.
    Schmidt RJ; Landry DL; Cohen L; Moss AH; Dalton C; Nathanson BH; Germain MJ
    Nephrol Dial Transplant; 2019 Sep; 34(9):1517-1525. PubMed ID: 30395311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and validation of a predictive model for Chronic Kidney Disease progression in Type 2 Diabetes Mellitus based on a 13-year study in Singapore.
    Low S; Lim SC; Zhang X; Zhou S; Yeoh LY; Liu YL; Tavintharan S; Sum CF
    Diabetes Res Clin Pract; 2017 Jan; 123():49-54. PubMed ID: 27923172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predicting 5-Year Risk of RRT in Stage 3 or 4 CKD: Development and External Validation.
    Schroeder EB; Yang X; Thorp ML; Arnold BM; Tabano DC; Petrik AF; Smith DH; Platt RW; Johnson ES
    Clin J Am Soc Nephrol; 2017 Jan; 12(1):87-94. PubMed ID: 28028051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prediction model on incident chronic kidney disease among individuals with type 2 diabetes in the United States.
    Lin Y; Shao H; Fonseca V; Anderson AH; Batuman V; Shi L
    Diabetes Obes Metab; 2023 Oct; 25(10):2862-2868. PubMed ID: 37334525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. External validation of the European risk assessment tool for chronic cardio-metabolic disorders in a Middle Eastern population.
    Asgari S; Moosaie F; Khalili D; Azizi F; Hadaegh F
    J Transl Med; 2020 Jul; 18(1):267. PubMed ID: 32615996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk models to predict chronic kidney disease and its progression: a systematic review.
    Echouffo-Tcheugui JB; Kengne AP
    PLoS Med; 2012; 9(11):e1001344. PubMed ID: 23185136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of Two Asian Noninvasive Risk Models for Predicting Prevalent Undiagnosed Chronic Kidney Disease in Diabetic Patients Receiving Care at a Reference Hospital in A Sub-Saharan African Country: A Cross-Sectional Study.
    Sih C; Choukem SP; Lubeka N; Kengne AP
    Saudi J Kidney Dis Transpl; 2022; 33(1):132-146. PubMed ID: 36647987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A prediction model on incident ESKD among individuals with T2D and CKD.
    Lin Y; Shao H; Fonseca V; Anderson AH; Batuman V; Shi L
    J Diabetes Complications; 2023 Apr; 37(4):108450. PubMed ID: 36871314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. External validation of a minimal-resource model to predict reduced estimated glomerular filtration rate in people with type 2 diabetes without diagnosis of chronic kidney disease in Mexico: a comparison between country-level and regional performance.
    Sammut-Powell C; Sisk R; Silva-Tinoco R; de la Pena G; Almeda-Valdes P; Juarez Comboni SC; Goncalves S; Cameron R
    Front Endocrinol (Lausanne); 2024; 15():1253492. PubMed ID: 38586458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel Risk Factors for Progression of Diabetic and Nondiabetic CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Anderson AH; Xie D; Wang X; Baudier RL; Orlandi P; Appel LJ; Dember LM; He J; Kusek JW; Lash JP; Navaneethan SD; Ojo A; Rahman M; Roy J; Scialla JJ; Sondheimer JH; Steigerwalt SP; Wilson FP; Wolf M; Feldman HI;
    Am J Kidney Dis; 2021 Jan; 77(1):56-73.e1. PubMed ID: 32866540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Predictive Model for Progression of CKD to Kidney Failure Based on Routine Laboratory Tests.
    Zacharias HU; Altenbuchinger M; Schultheiss UT; Raffler J; Kotsis F; Ghasemi S; Ali I; Kollerits B; Metzger M; Steinbrenner I; Sekula P; Massy ZA; Combe C; Kalra PA; Kronenberg F; Stengel B; Eckardt KU; Köttgen A; Schmid M; Gronwald W; Oefner PJ;
    Am J Kidney Dis; 2022 Feb; 79(2):217-230.e1. PubMed ID: 34298143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between fatty liver index and risk of end-stage renal disease stratified by kidney function in patients with type 2 diabetes: A nationwide population-based study.
    Chung GE; Han K; Lee KN; Bae JH; Yang SY; Choi SY; Yim JY; Heo NJ
    Diabetes Metab; 2023 Jul; 49(4):101454. PubMed ID: 37244418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risks of Adverse Events in Advanced CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.
    Grams ME; Yang W; Rebholz CM; Wang X; Porter AC; Inker LA; Horwitz E; Sondheimer JH; Hamm LL; He J; Weir MR; Jaar BG; Shafi T; Appel LJ; Hsu CY;
    Am J Kidney Dis; 2017 Sep; 70(3):337-346. PubMed ID: 28366517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Performance of the Kidney Failure Risk Equation by Disease Etiology in Advanced CKD.
    Hundemer GL; Tangri N; Sood MM; Ramsay T; Bugeja A; Brown PA; Clark EG; Biyani M; White CA; Akbari A
    Clin J Am Soc Nephrol; 2020 Oct; 15(10):1424-1432. PubMed ID: 32928746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors, outcomes and healthcare utilisation in individuals with multimorbidity including heart failure, chronic kidney disease and type 2 diabetes mellitus: a national electronic health record study.
    Pasea L; Dashtban A; Mizani M; Bhuva A; Morris T; Mamza JB; Banerjee A
    Open Heart; 2023 Sep; 10(2):. PubMed ID: 37758654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of kidney disease outcomes with risk factors for CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) study.
    Yang W; Xie D; Anderson AH; Joffe MM; Greene T; Teal V; Hsu CY; Fink JC; He J; Lash JP; Ojo A; Rahman M; Nessel L; Kusek JW; Feldman HI;
    Am J Kidney Dis; 2014 Feb; 63(2):236-43. PubMed ID: 24182662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.
    Koye DN; Magliano DJ; Reid CM; Jepson C; Feldman HI; Herman WH; Shaw JE
    Am J Kidney Dis; 2018 Nov; 72(5):653-661. PubMed ID: 29784612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.